Here are some of the things you should be reading in this issue of Endocrine News.
Parallel Lives: Endocrine Research & Gender Affirmation—Two studies from ENDO 2019 shed new light on gender dysphoria for patients undergoing gender-affirming surgery (GAS). A study of transgender women demonstrated the importance of hormone replacement after GAS while another study of transgender men showed that preserving ovarian reserve could allow for future reproduction
Expanding Horizons: A Look at the Endocrine Society’s Evolving Minority Outreach—The Endocrine Society’s minority outreach has steadily evolved from simply a “good idea” 20 years ago into a life-changing program for hundreds of minority endocrinologists for generations to come.
Within Reach: How Can Endocrinology Help Cure All Diseases?—When Cori Bargmann, PhD, president of science of the Chan Zuckerberg Initiative, spoke at ENDO 2019 in New Orleans, she explained how endocrine science and practice can play a vital role in curing — or at least managing — all disease by the year 2100.
Young & Restless: BPA, Circadian Rhythms & Hyperactivity—From obesity to autism, the effects of bisphenol A (BPA) during pregnancy and childhood are well known. However, new research shows that BPA exposure during pregnancy at levels once considered safe could disrupt circadian rhythms as well as lead to hyperactivity later in life.
And so much more.
We have extended our abstract submission deadline to Monday, November 2. With over 150 topical areas for abstract submissions, don’t miss this chance to share your science and expand the reach of your work. Please use these extra few days to finalize your abstract and complete your submission.
